Page 748 - medicina-integrativa_compress

CAPÍTULO 70 URTICARIA 763

Cetirizina (Zyrtec ): 10 mg 1 o 2 veces Zafirlukast (Accolate ): 20 mg 2 veces al día.
®
®
al día.
®
Montelukast (Singulair ): 10 mg 1 vez al día.
• Antagonistas H 2 :
®
Zileutón (Zyflo ): 600 mg hasta 4 veces al día.
Ranitidina (Zantac ): 150-300 mg 2 veces
®
al día. • Corticoides: 60 mg/día durante 2 a 3 días,
seguido de una reducción gradual de la A A 2 2
Famotidina (Pepcid ): 20-40 mg 1 a 2 veces dosis durante 1 a 2 semanas
®
al día
Cimetidina (Tagamet ): 200-400 mg 1 a ■ Técnicas mente-cuerpo
®
4 veces al día.
• Relajación: muy recomendable para todo
tipo de paciente.
• Doxepina: 10-75 mg antes de acostarse. C 1
B B 2 2
• Hipnosis: especialmente en las personas
• Inhibidores de leucotrienos:
clasificadas como hipnotizables. C 1
C 1
BIBLIOGRAFÍA 20. Alper BS: Choice of antihistamines for urticaria. Arch Fam Med
9:748-751, 2000.
1. Grattan CEH, Black AK: Urticaria and angioedema. In Bolognia JL, 21. Kaplan AP: Chronic urticaria and angioedema. N Engl J Med
Jorizzo JL, Rapini RP (eds): Dermatology. Mosby, 2003, pp 287-302. 346:175-179, 2002.
2. Al-Abdulla IH, Greally J: C1-inhibitor-biochemical properties and 22. Wanderer AA, Bernstein IL, Goodman DL, et al: The diagnosis and
clinical applications. Crit Rev Immunol 5:317-330, 1985. management of urticaria: A practice parameter. Ann Allergy Asthma
3. Chan CL, Jones RL, Lau HYA: Characterization of prostanoid Immunol 85:532-544, 2000.
receptors mediating inhibition of histamine release from 23. Bleehan SS, et al: Cimetidine and chlorpheniramine in the
anti-IgE-activated rat peritoneal mast cells. Br J Pharmacol treatment of chronic idiopathic urticaria: A multi-centre
129:589-597, 2000. randomized double-blind study. Br J Dermatol 117:81-88, 1987.
4. Juhlin L: Recurrent urticaria: Clinical investigation of 330 patients. 24. Green SL, Reed CE, Schroeter AL: Double-blind crossover study
Br J Dermatol 104:369-381, 1981. comparing doxepin with diphenhydramine for the treatment of
5. Grattan C, Powell S, Humphreys F: Management and diagnostic chronic urticaria. J Am Acad Dermatol 12:669-675, 1985.
guidelines for urticaria and angio-oedema. Br J Dermatol 25. Stanaland BE: Treatment of patients with chronic idiopathic
144:708-714, 2001. urticaria. Clin Rev Allergy Immunol 23:233-241, 2002.
6. Berg RF, Kantor GR, Bergfeld WF: Urticarial vasculitis. Int J 26. Bensch G, Borish L: Leukotriene modifiers in chronic urticaria.
Dermatol 27:468-472, 1988. Ann Allergy Asthma Immunol 83:348, 1999.
7. Sanchez NP, Winkelmann RK, Schroeter AL, et al: The clinical and 27. Di Lorenzo G, et al: Randomized placebo-controlled trial comparing
histopathologic spectrums of urticarial vasculitis: A study of forty desloratadine and montelukast in monotherapy and desloratadine
cases. J Am Acad Dermatol 7:599-605, 1982. plus montelukast in combined therapy for chronic idiopathic
8. Zuberbier T, et al: Pseudoallergen-free diet in the treatment of urticaria. J Allerg Clin Immunol 114:619-625, 2004.
chronic urticaria. J Eur Acad Dermatol Venereol 75:484-487, 1995. 28. Kimyai-Asadi A. Usman A: The role of psychological stress in skin
9. Guida B, et al: Histamine plasma levels and elimination diet in disease, J Cutan Med Surg 5(2):140-145, 2001.
chronic idiopathic urticaria. Eur J Clin Nutr 54:155-158, 2000. 29. Picardi A, Abeni D: Stressful life events and skin diseases:
10. Balch PA, Balch JF: Prescription for Nutritional Healing, 3rd ed. disentangling evidence from myth, Psychotherapy & Psychosomatics
New York, Penguin Putnam, 2000, pp 443-446. 70(3):118-136, 2001.
© Elsevier. Es una publicación MASSON. Fotocopiar sin autorización es un delito.
11. Alternative Medical Review 3:140-143, 1998. 30. Wallengren J, Moller H, Ekman R: Occurrence of substance P,
12. Thomet OA, Schapowal A, Heinisch IV, et al: Anti-inflammatory vasoactive intestinal peptide, and calcitonin gene-related peptide in
activity of an extract of Petasites hybridus in allergic rhinitis. dermographism and cold urticaria, Arch Dermatol Research
Int Immunopharmacol 2:997-1006, 2002. 279(8):512-515, 1987.
13. Lee DK, Carstairs IJ, Haggart K, et al: Butterbur, a herbal remedy, 31. Church MK, et al: Allergy or inflammation? From neuropeptide
attenuates adenosine monophosphate induced nasal responsiveness stimulation of human skin mast cells to studies on the
in seasonal allergic rhinitis. Clin Exp Allergy 33:882-886, 2003. mechanism of the late asthmatic response, Agents Actions 26(1-2):
14. Schapowal A: Petasites Study Group. Randomised controlled trial 22-30, 1989.
of butterbur and cetirizien for treating seasonal allergic rhinitis. 32. Zachariae R, Bjerring P, Arendt-Nielsen L: Modulation of type I
BMJ 324:144-146, 2002. immediate and type IV delayed immunoreactivity using suggestion
15. Newall CA, Anderson LA, Philpson JD: Herbal Medicine: A Guide and guided imagery during hypnosis, Allergy 44:537-542, 1989.
for Healthcare Professionals. Chicago, The Pharmaceutical Press, 33. Zachariae R, Bjerring P: The effect of hypnotically induced analgesia
1996. on flare reaction of the cutaneous histamine prick test, Arch
16. Inoue T, Sugimoto Y, Masuda H, et al: Antiallergic effect of Dermatol Res 282:539-543, 1990.
flavonoid glycosides obtained from Mentha piperita. Biol 34. Shertzer CL, Lookingbill DP: Effects of relaxation therapy and
Pharmaceut Bull 25:256-259, 2002. hypnotizability in chronic urticaria, Arch Dermatol 123(7):
17. Simone FER: Advances in H1-antihistamines. N Engl J Med 913-916, 1987.
351:2203-2217, 2004. 35. Xu Yihou: Dermatology in Traditional Chinese Medicine, Donica
18. Ciprandi G, Passalacqua G, Canonica GW: Effects of H 1 Publishing. 2004, pp 231-250.
antihistamines on adhesion molecules: A possible rationale for 36. Chen CJ, Yu HS: Acupuncture Treatment of Urticaria, Arch
long-term treatment. Clin Exp Allergy 29(Suppl 3):49-53, 1999. Dermatol 134(11):1397-1399, 1998.
19. Breneman DL: Cetirizine versus hydroxyzine and placebo in chronic 37. Shah R, Shah R: Kali carbonicum: www.e-homoeopathy.com/
idiopathic urticaria. Ann Pharmacother 30:1075-1079, 1996. medimore.htm